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High fat dietFicus dalhousiae stem bark is used to treat cancer and hyperlipidemia in folklore practices. F. dalhousiae
stem bark methanolic extract (250 and 500 mg/kg b. wt.) was evaluated for antihyperlipidemic activity
in Triton WR-1339 and high fat diet-induced hyperlipidemic rats. F. dalhousiae extract significantly
(P 6 0.005) alter the serum TC, TG, LDL-C and HDL-C levels to near normal in Triton WR-1339 and high
fat diet-induced hyperlipidemic rats. The liver total cholesterol and triglycerides were also significantly
reduced after treatment with 250 and 500 mg/kg of F. dalhousiae. The result of this study indicates that
F. dalhousiae has a significant potential to use as a natural antihyperlipidemic agent.
 2016 Publishing services provided by Elsevier B.V. on behalf of Faculty of Pharmacy, Cairo University.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Metabolic disorders that involve elevations in any lipoprotein
species are termed as hyperlipidemias or hyperlipoproteinemias.
The disease is characterized by elevated serum total cholesterol,
low density lipoprotein, very low density lipoprotein level and
decreased high density lipoprotein levels [1,2]. It occurs mainly
due to impaired lipid and lipoprotein metabolism which adversely
affects the pathways of cholesterol transport as well. The lipid
metabolism is largely affected by host of risk factors which include
lack of physical activities, sedentary life style, and diet enriched
with cholesterol saturated fats, obesity, age and hormonal dysreg-
ulation [3,4]. Hyperlipidemia associated lipid disorders are consid-
ered to cause atherosclerotic cardiovascular diseases.
Hypertriglyceridemia and hypercholesterolemia are closely related
to the development of ischemic heart disease [5,6].
Statin, fibrates, niacin and resins are mainly used for the treat-
ment of cardiovascular diseases but these are linked with a num-
ber of adverse effects. The following are the main ill-effects:
flushing, dry skin, diarrhoea, nausea, muscle-related complaints,
such as gastric irritation, abnormal liver function, rhabdomyolysis,
myalgia, cramps, and muscle weakness (i.e., myopathy) [7,8]. In
addition to this statins provoke liver dysfunction and renal failure[9,10]. Therefore, the development of promising cholesterol-
lowering treatment alternatives to allopathic drugs is of utmost
importance.
Evaluation of phytochemicals as new drug candidates for treat-
ing hyperlipidemia is a hopeful attempt. A lot of inhibitors of
cholesterol synthesis e.g., flavonoids [11,12] and dietary fiber
[13] are originated from natural sources and efficiently lower blood
cholesterol level.
Ficus dalhousiae miq. belonging to the family Moraceae. These
are very rare species and found in the Nilgiri mountains at the alti-
tudinal range of 605–1370 m. It is a tree of 10 m high, bark brown
in colour, leaves are simple and ovate. The plant is seen in moist
deciduous forests, endemic to Southern Western Ghats. Wherever
it grows, its population size is very small and probably that is the
reason for its inclusion under the very rare category in the threat-
ened plant list [14]. Fruit is used as cardiotonic, leaves and bark are
mainly used in liver and skin diseases. Leaf juice posses antidysen-
teric activity. Roots are antispasmodic. Bark is used to treat cancer
and hyperlipidemia in folklore practice [15]. From the literature
survey it has seen that F. dalhousiae bark has not been evaluated
for any pharmacological activity. In leaves, antihyperglycemic
[16], gastroprotective [17], in vitro antioxidant [18] activities have
been reported. This study was aimed to evaluate the antihyperlipi-
demic effects of F. dalhousiae bark in Triton WR-1339 and high fat
diet-induced hyperlipidemic rats.nduced
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2.1. Plant material
F. dalhousiae stem bark were collected from the surrounding
regions of Jawaharlal Nehru Tropical Botanical Garden and
Research Institute (JNTBGRI), Palode, Thiruvananthapuram, Kerala
during the month of February–March, 2014. The plant was identi-
fied with the help of JNTBGRI taxonomist Dr. T. Sabu. A voucher
specimen has been deposited at the herbarium of the institute.2.2. Preparation of plant extracts
The collected barks of F. dalhousiae were chopped, dried and
powdered. The powder (2 kg) was subjected to soxhelation process
for 72 h at room temperature using methanol as solvent. The fil-
trate was evaporated to dryness in a rotary evaporator at 40 C
under reduced pressure and stored in a refrigerator at 2–8 C for
further use in experiments. The percentage yield of methanol
extract of F. dalhousiae bark was found to be 2.73% w/w.2.3. Experimental animals
Wistar albino rats (180–200 g) were used in this study. Animals
were procured from Govt. veterinary animal house mannuthy,
approved by Committee for the Purpose of Control and Supervision
of Experiments on Animals (CPCSEA). All animals were kept in
polyacrylic cages and maintained under standard housing condi-
tions (room temperature 24–27 C and humidity 60–65% with
12:12 light: dark cycles). Commercial pellet diet and water were
provided ad libitum. The experiments were carried out according
to the guidelines approved by the Institutional Animal Ethical
Committee. Reg. No. SJCP/IAEC/05/2014.2.4. Preliminary phytochemical screening of F. dalhousiae
The preliminary phytochemical analysis was carried out using
the standard phytochemical methods of Harborne [19].2.5. Acute toxicity study
The doses for the study were fixed based on Irwin test [20]. No
mortality and behavioral alterations (physical signs of toxicity,
such as writhing, gasping, palpitation and decreased respiratory
rate) were observed in F. dalhousiae bark extract treated rats. There
was no lethality or toxic reaction found at any selected dose until
the end of the study.2.6. Hypolipidemic activity in Triton WR-1339 induced rats
2.6.1. Induction of hyperlipidemia
This study was to examine the short-term effects of F. dalhou-
siae bark extract on Triton-induced hyperlipidemic rats. Wistar rats
weighing between 180 and 200 g were used for the study. The
hyperlipidemia was induced by the intraperitoneal injection of Tri-
ton WR-1339 (200 mg/kg) (Sigma Chemical Co., USA) dissolved in
phosphate buffered saline (pH 7.4) [21]. The rats were starved
overnight and divided into five groups of six rats each.
Group I served as normal control rats treated with vehicle;
Group II-V were given intraperitoneal injection of Triton WR-
1339; Group II hyperlipidemic rats were treated with vehicle
alone; Group III and IV hyperlipidemic rats were treated with
F. dalhousiae bark extract 250 and 500mg/kg, respectively; Group V
hyperlipidemic rats were treated with Fenofibrate (65 mg/kg).Please cite this article in press as: S. Surya et al., Antihyperlipidemic effect of Fic
hyperlipidemic rats, Bulletin Facult Pharmacy Cairo Univ (2016), http://dx.doiAll the treatments were given orally, immediately after Triton
injection. In the following period of study (18 h), rats had access
only to water. After 18 h of treatment, the rats were euthanized
and blood was collected. The blood samples were immediately
centrifuged (2500 rpm/15 min) and the plasma was used for lipid
analysis.2.7. Effect of F. dalhousiae bark extract on high fat diet induced
hyperlipidemic rats
2.7.1. Induction of hyperlipidemia
The long-term hypolipidemic effect of F. dalhousiae extract was
studied in high fat diet fed-obese hyperlipidemic rat model. Male
Wistar rats weighing 180–200 g were used in this study. The rats
were fed with a high-fat diet composed of standard rat chow
68%, dalda (saturated fat) 30%, and cholesterol 2% for 15 days
[22]. The rats were divided into five groups, with six rats in each
group. Group I was normal control rats fed with normal pellet diet
and treated with the vehicle; Group II hyperlipidemic control rats
were fed with high-fat diet and treated with the vehicle; Group III
and IV hyperlipidemic rats were fed with high-fat diet and treated
with F. dalhousiae extract at 250 and 500 mg/kg, respectively;
Group V hyperlipidemic positive control rats were fed with high-
fat diet and treated with Fenofibrate (65 mg/kg). Treatments were
given once daily continuously for 28 days, orally. On days 0, 7, 14,
21, and 28, the blood samples was collected by retro orbital sinus
and the TC, TG, HDL-C, and LDL-C levels were measured using diag-
nostic kits (Sigma Diagnostic, Inc., USA) [23]. At the end of the
study, the rats were sacrificed, and blood and liver samples were
collected. The liver samples were stored at 70 C for the analysis
of the TC and TG levels.2.7.2. Biochemical analysis of serum
The TC, TG, and HDL-C levels were quantified using enzymatic
kits (Sigma Diagnostic, Inc., USA). The LDL-C level was calculated
using the formula of Friedewald et al. [24]: LDL-C = TC  (HDL-
C  TG/5), where TC is the total cholesterol level and TG is the
triglycerides level.2.8. Statistical analysis
The results were presented as mean ± SEM. Statistical analyses
of all the data obtained were evaluated using one-way ANOVA fol-
lowed by Student’s t-test (SPSS Program; Version 11.5). The differ-
ences were considered as significant at P 6 0.05.3. Results
3.1. Preliminary phytochemical analysis
The preliminary phytochemical evaluation of F. dalhousiae bark
extract showed the presence of coumarins, flavonoids, steroids and
tannins.3.2. F. dalhousiae bark extract on Triton induced hyperlipidemia
The plasma TC, TG, LDL-C, and HDL-C levels of F. dalhousiae bark
extract (250 and 500 mg/kg) treated groups were shown in Table 1.
In comparison with the normal control group, Triton caused a
marked increase on the plasma TC, TG, and LDL-C levels, and a
decrease in the HDL-C level. After treatment with 250 and
500 mg/kg of the extract, F. dalhousiae bark extract (250 and
500 mg/kg) significantly reduced the levels of TC (P 6 0.05
and P 6 0.005), TG (P 6 0.05 and P 6 0.005), and LDL-C (P 6 0.005us dalhousiae miq. stem bark on Triton WR-1339 and high fat diet-induced
.org/10.1016/j.bfopcu.2016.10.003
Table 1
Effect of F. dalhousiae bark extract on the Triton-induced hyperlipidemic rat model.
Groups TC (mg/dl) TG (mg/dl) LDL-C (mg/dl) HDL-C (mg/dl)
Normal control 70.31 ± 2.81 103.73 ± 2.73 60.18 ± 4.29 0.60 ± 0.03
Triton 250.18 ± 3.18 652.81 ± 2.91 205.11 ± 6.31 0.32 ± 0.03
Triton + ME (250 mg/kg) 243.76 ± 2.31⁄ 631.71 ± 1.21⁄⁄ 193.81 ± 2.73⁄ 0.36 ± 0.03⁄
Triton + ME (500 mg/kg) 220.31 ± 2.89⁄⁄ 502.2 ± 2.41⁄⁄ 162.17 ± 3.81⁄⁄ 0.42 ± 0.09⁄⁄
Triton + F (65 mg/kg) 140.23 ± 4.81⁄⁄ 262.73 ± 2.81⁄⁄ 73.81 ± 2.85⁄⁄ 0.59 ± 0.02⁄⁄
Values are mean ± SEM (n = 6). ⁄P 6 0.05, ⁄⁄P 6 0.005, compared with the hyperlipidemic control values. ME-methanol extract, F-Fenofibrate.
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levels.
3.3. F. dalhousiae bark extract on high fat diet induced hyperlipidemia
The plasma TC, TG, LDL-C and HDL-C levels of F. dalhousiae bark
extract (250 and 500 mg/kg) treated groups on day 0, 7, 14, 21, and
28 were shown in Table 2. Normal rats fed with high-fat diet for
15 days showed increased plasma TC, TG, and LDL-C, and
decreased HDL-C levels. After treatment with F. dalhousiae bark
extract for 28 days, the lipid levels of 250 and 500 mg/kg treated
animals (P 6 0.05 and P 6 0.005) significantly altered the levels
near to normal.
The levels of liver TC and TG of normal and hyperlipidemic rats
are shown in Fig. 1. The normal rats fed with high-fat diet for
15 days showed a significant increase (P 6 0.005) in the TC and
TG levels of the liver. After treatment with methanol extract (250
and 500 mg/kg), the TC and TG levels of the liver were reduced
to normal levels.
4. Discussion
Triton WR-1339 a non-ionic detergent inhibits the catabolising
enzymes lipoprotein lipase (LPL) and lecithin cholesterol acetyl
transferase (LCAT) by blocking the uptake of lipoprotein from the
circulation by extra hepatic tissues, which cause an increase in
the level of circulatory lipoproteins. Triton WR-1339 detergent
has been used to evaluate the acute hypolipidemic effect on animal
models. We evaluated the effect of F. dalhousiae (250 and 500 mg/
kg) in triton induced hyperlipidemic rats. The methanol extractTable 2
Effect of F. dalhousiae bark extract on serum TC, TG, LDL-C, and HDL-C levels of control an
Parameter Groups 0 day 7th day
TC NC 76.48 ± 7.48 77.64 ± 8.3
HC 145.83 ± 2.38 157.87 ± 6
HC + ME (250 mg/kg) 142.38 ± 2.37 130.58 ± 5
HC + ME (500 mg/kg) 144.38 ± 3.58 140.38 ± 1
HC + F (65 mg/kg) 147.26 ± 4.32 120.53 ± 6
TG NC 97.26 ± 3.81 99.28 ± 7.3
HC 206.25 ± 4.79 245.63 ± 5
HC + ME (250 mg/kg) 221.14 ± 3.25 227.24 ± 4
HC + ME (500 mg/kg) 242.38 ± 6.33 223.18 ± 4
HC + F (65 mg/kg) 232.18 ± 6.38 197.38 ± 5
LDL-C NC 37.63 ± 3.28 41.78 ± 9.1
HC 93.24 ± 4.47 110.95 ± 6
HC + ME (250 mg/kg) 125.53 ± 3.67 120.83 ± 2
HC + ME (500 mg/kg) 120.89 ± 2.43 110.34 ± 2
HC + F (65 mg/kg) 126.68 ± 1.72 110.32 ± 2
HDL-C NC 37.23 ± 3.39 36.86 ± 9.3
HC 32.10 ± 5.25 28.254 ± 4
HC + ME (250 mg/kg) 34.78 ± 7.89 35.28 ± 3.5
HC + ME (500 mg/kg) 34.62 ± 3.31 37.42 ± 2.2
HC + F (65 mg/kg) 35.30 ± 4.03 41.62 ± 5.2
Values are mean ± SEM (n = 6). ⁄P 6 0.05, ⁄⁄P 6 0.005, compared with the hyperlipidemic c
F-Fenofibrate.
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hyperlipidemic rats, Bulletin Facult Pharmacy Cairo Univ (2016), http://dx.doi.(250 and 500 mg/kg) reduced the TC, TG, and LDL-C, and increased
the HDL-C levels significantly compared to the hypolipidemic con-
trol rats. The lipid-lowering effect of F. dalhousiae extract in rats
may be due to the inhibition of cholesterol biosynthesis and
increased fecal bile acid excretion [25]. The methanol extract of
F. dalhousiae was further evaluated in high fat diet-induced hyper-
lipidemic rats. The cholesterol level was reduced significantly this
may be due to the increase in activity of LCAT, which plays impor-
tant role in regulation of blood lipids. LCAT plays a key role in
incorporating free cholesterol into HDL and transferring back to
VLDL or IDL, which is taken back by the liver cells. Several studies
show that an increase in HDL cholesterol is associated with a
decrease in coronary risk [26] and most of the drugs that decrease
total cholesterol also decrease HDL cholesterol [27]. But in the pre-
sent study, the extract of F. dalhousiae decreased the total choles-
terol and LDL cholesterol and enhanced the HDL cholesterol
significantly. This is an important advantage in treatment of hyper-
cholesterolemia especially among Indians where low HDL choles-
terol is the prevalent lipoprotein abnormality. LDL cholesterol is
major coronary risk factors for atherosclerosis [28,29]. LDL carries
cholesterol from the liver to the peripheral cells and smooth mus-
cle cells of the arteries, a rise in LDL may cause deposition of
cholesterol in the arteries and aorta and hence it is bad for health
and a direct risk factor for coronary heart disease [30,31]. Admin-
istration of F. dalhousiae lowered both total and LDL cholesterol in
experimental rats. The lowering of TC and LDL in serum by F. dal-
housiae would reduce the incidence of coronary events. The
decrease of serum TG level is an important finding of this experi-
ment. Recent studies also showed that triglycerides are indepen-
dently related to coronary heart disease [32,33] and most of thed treated rats on day 0, 7, 14, 21, and 28 of the high fat diet-induced rat model.
14th day 21st day 28th day
7 79.37 ± 2.37 76.37 ± 4.37 77.38 ± 3.28
.38 162.45 ± 7.38 169.36 ± 2.37 178.36 ± 5.38
.28⁄ 120.62 ± 3.88⁄⁄ 109.34 ± 4.38⁄⁄ 101.52 ± 5.09⁄⁄
.66⁄ 101.81 ± 9.26⁄ 92.12 ± 2.11⁄⁄ 82.45 ± 3.19⁄⁄
.18⁄ 94.24 ± 1.58⁄⁄ 87.23 ± 2.41⁄⁄ 80.18 ± 1.09⁄⁄
1 100.16 ± 4.83 99.22 ± 3.92 99.38 ± 4.84
.37 253.18 ± 4.27 259.78 ± 2.68 261.21 ± 5.24
.68 221.48 ± 3.28⁄⁄ 190.22 ± 4.18⁄⁄ 181.31 ± 3.19⁄⁄
.28⁄ 202.58 ± 7.97⁄⁄ 194.34 ± 7.14⁄⁄ 180.65 ± 6.89⁄⁄
.68⁄⁄ 183.75 ± 5.48⁄⁄ 163.78 ± 6.47⁄⁄ 143.62 ± 8.39⁄⁄
8 40.18 ± 2.35 40.18 ± 2.38 41.30 ± 2.21
.58 115.16 ± 8.59 126.43 ± 3.39 130.61 ± 3.74
.89 120.83 ± 7.42 115.36 ± 2.89⁄ 110.31 ± 2.81⁄⁄
.43 109.31 ± 2.82 104.31 ± 2.21⁄⁄ 97.83 ± 4.54⁄⁄
.18⁄ 92.58 ± 9.40⁄⁄ 86.78 ± 5.32⁄⁄ 75.78 ± 5.21⁄⁄
7 35.52 ± 4.89 37.54 ± 2.62 36.62 ± 4.30
.20 27.42 ± 5.20 26.20 ± 2.01 25.08 ± 1.19
0 35.67 ± 4.19 40.44 ± 5.33⁄ 43.58 ± 3.20⁄⁄
9 39.85 ± 4.20 40.31 ± 1.29⁄ 42.21 ± 5.21⁄⁄
1 48.42 ± 4.37⁄ 52.26 ± 3.33⁄⁄ 56.37 ± 10.28⁄⁄
ontrol values. NC-normal control, HC-hyperlipidemic control, ME-methanol extract,
us dalhousiaemiq. stem bark on Triton WR-1339 and high fat diet-induced
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Fig. 1. Effect of F. dalhousiae bark extract on the liver TC and TG levels in rats fed with high-fat diet after 28 days of treatment. Values are mean ± SEM (n = 6). ⁄P 6 0.05,
⁄⁄P 6 0.005, compared with the hyperlipidemic control values. NC- normal control, HC- hyperlipidemic control, ME- methanol extract, F- Fenofibrate.
4 S. Surya et al. / Bulletin of Faculty of Pharmacy, Cairo University xxx (2016) xxx–xxxantihypercholesterolemic drugs do not decrease triglycerides
levels, but F. dalhousiae lowered it significantly and this effect
might be related to increase the endothelium bound lipoprotein
lipase which hydrolyses the triglycerides into fatty acids. The pres-
ence of ficusin have been reported in ficus species [34]. Ficusin
showed antihyperlipidemic effect in high fat diet – streptozotocin
induced diabetic rats [35]. The presence of this compound in F. dal-
housiae may responsible for the antihyperlipidemic effect.5. Conclusion
From the study, it has been proved that the methanol extract of
F. dalhousiae stem bark has antihyperlipidemic effect in triton WR-
1339 and high fat diet-induced hyperlipidemic rats. Further stud-
ies on isolation and identification of the active molecule will pro-
vide a new drug for clinical use.Conflict of interest
None declared.
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